ProShare Advisors LLC Acquires Shares of 16,872 First Advantage Co. (NYSE:FA)

ProShare Advisors LLC purchased a new position in First Advantage Co. (NYSE:FA - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 16,872 shares of the company's stock, valued at approximately $316,000.

Other hedge funds have also recently modified their holdings of the company. Summit Investment Advisors Inc. increased its position in First Advantage by 15.3% during the fourth quarter. Summit Investment Advisors Inc. now owns 6,267 shares of the company's stock valued at $117,000 after acquiring an additional 832 shares during the last quarter. BNP Paribas Financial Markets purchased a new stake in First Advantage during the fourth quarter valued at $132,000. Two Sigma Securities LLC purchased a new stake in First Advantage during the fourth quarter valued at $188,000. Tower Research Capital LLC TRC increased its position in First Advantage by 1,219.4% during the fourth quarter. Tower Research Capital LLC TRC now owns 10,555 shares of the company's stock valued at $198,000 after acquiring an additional 9,755 shares during the last quarter. Finally, Pictet Asset Management Holding SA purchased a new stake in First Advantage during the fourth quarter valued at $210,000. Hedge funds and other institutional investors own 94.91% of the company's stock.

Analyst Ratings Changes

A number of analysts recently commented on the company. William Blair reiterated an "outperform" rating on shares of First Advantage in a research report on Friday, February 28th. Barclays upped their price objective on First Advantage from $15.00 to $18.00 and gave the company an "equal weight" rating in a research report on Thursday, May 29th. Needham & Company LLC reissued a "hold" rating on shares of First Advantage in a report on Monday. BMO Capital Markets cut their price target on First Advantage from $24.00 to $22.00 and set an "outperform" rating for the company in a report on Monday, March 3rd. Finally, Royal Bank of Canada lowered First Advantage from an "outperform" rating to a "sector perform" rating and set a $20.00 price target for the company. in a report on Friday, May 9th. Five equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company's stock. According to MarketBeat, the company has a consensus rating of "Hold" and an average price target of $66.00.

First Advantage Price Performance

Shares of NYSE FA traded up $0.65 during mid-day trading on Tuesday, reaching $18.10. The company's stock had a trading volume of 899,030 shares, compared to its average volume of 842,895. The firm has a market capitalization of $3.14 billion, a PE ratio of 603.33 and a beta of 1.20. The company has a debt-to-equity ratio of 0.61, a current ratio of 3.85 and a quick ratio of 3.85. The stock has a fifty day moving average of $15.45 and a two-hundred day moving average of $16.93. First Advantage Co. has a 52 week low of $12.32 and a 52 week high of $20.79.

First Advantage (NYSE:FA - Get Free Report) last announced its quarterly earnings results on Thursday, May 8th. The company reported $0.17 EPS for the quarter, beating analysts' consensus estimates of $0.13 by $0.04. First Advantage had a return on equity of 13.16% and a net margin of 0.65%. During the same quarter last year, the firm earned $0.17 earnings per share. The business's quarterly revenue was up 109.3% compared to the same quarter last year. As a group, sell-side analysts anticipate that First Advantage Co. will post 0.74 EPS for the current fiscal year.

About First Advantage

First Advantage Corporation provides employment background screening, identity, and verification solutions worldwide. It offers pre-onboarding products and solutions, such as criminal background checks, drug/health screening, extended workforce screening, FBI channeling, identity checks and biometric fraud mitigation tools, education/work history verification, driver records and compliance, healthcare credentials, executive screening, and other screening products.